bc-2核酶与Bax在诱导食管癌细胞凋亡中的协同作用

为了同时调节二种凋亡相关蛋白的表达诱导肿瘤细胞凋亡,探索肿瘤基因治疗的可能性,同时转入可诱导表达的特异性切割bcl-2的核酶基因及bax基因,间接免疫荧光标记法检测Bcl-2及Bax蛋白的表达量,用TUNEL、流式细胞术及琼脂糖凝胶电泳检测细胞凋亡.共转染后Bcl-2蛋白表达下降,同时Bax蛋白表达升高,导致30%左右细胞凋亡,并可使细胞对紫杉醇的敏感度增加近4倍,使紫杉醇有效作用时间缩短近一倍.同时调节二个凋亡相关基因可导致细胞凋亡,并能有效促进化疗药物诱导的凋亡.同时校正多个基因的异常表达,比仅仅改变单个基因可更有效地达到治疗肿瘤的目的.     

bcl-2核酶与Bax在诱导食管癌细胞凋亡中的协同作用

为了同时调节二种凋亡相关蛋白的表达诱导肿瘤细胞凋亡 ,探索肿瘤基因治疗的可能性 ,同时转入可诱导表达的特异性切割 bcl- 2的核酶基因及 bax基因 ,间接免疫荧光标记法检测 Bcl- 2及Bax蛋白的表达量 ,用 TUNEL、流式细胞术及琼脂糖凝胶电泳检测细胞凋亡 .共转染后 Bcl- 2蛋白表达下降 ,同时 Bax蛋白表达升高 ,导致 30 %左右细胞凋亡 ,并可使细胞对紫杉醇的敏感度增加近4倍 ,使紫杉醇有效作用时间缩短近一倍 .同时调节二个凋亡相关基因可导致细胞凋亡 ,并能有效促进化疗药物诱导的凋亡 .同时校正多个基因的异常表达 ,比仅仅改变单个基因可更有效地达到治疗肿瘤的目的 .     

金松双黄酮联合紫杉醇对肺癌A549细胞生长及凋亡的影响

目的:研究金松双黄酮联合紫杉醇对肺癌A549细胞生长及凋亡的影响及其可能的机制。方法:取对数生长的肺癌A549细胞,分为对照组、紫杉醇组、金松双黄酮组、金松双黄酮联合紫杉醇组。采用MTT法研究金松双黄酮联合紫杉醇对肺癌A549细胞生长的影响;流式细胞术检测细胞凋亡率;蛋白免疫印迹法检测A549细胞中Bcl-2、Bax蛋白的表达。结果:金松双黄酮联合紫杉醇对肺癌A549细胞的生长抑制率高达64.81%,显著强于单纯紫杉醇作用组(P0.05),且两药合用可显著升高肺癌A549细胞的凋亡率(P0.01),并抑制凋亡相关蛋白Bcl-2蛋白的表达,上调Bax的表达。结论:金松双黄酮联合紫杉醇能够增强紫杉醇对肺癌A549细胞生长的抑制作用,促进细胞凋亡,其作用机制可能与调节凋亡基因Bc1-2、Bax的蛋白表达有关。     

HBXIP基因对乙肝病毒X蛋白诱导细胞凋亡的影响

探讨乙型肝炎病毒X蛋白结合蛋白(hepatitisBXinteractingprotein ,HBXIP)基因在乙型肝炎病毒X蛋白(HBX)诱导肝癌细胞凋亡时对细胞周期的影响.构建HBXIP基因真核表达载体pcDNA3 hbxip ,进行瞬时基因转染,将克隆有HBx基因的pCMV X (分别为1μg、2 μg和3μg)和pcDNA3 hbxip质粒分别和共转染至人H74 0 2肝癌细胞中(总体积分别为5 0 μl) .发现瞬时转染3μgpCMV X质粒后,肝癌细胞凋亡发生率为34 4 % ,肝癌细胞的细胞周期相关蛋白p2 7表达水平发生明显上调;与对照组相比,瞬时转染1μg、2 μg和3μg时,细胞周期蛋白D和细胞周期蛋白E的表达水平均发生明显上调,但随着HBX水平的增加细胞周期蛋白D和细胞周期蛋白E的表达水平发生明显下降;在稳定转染pCMV X质粒的H74 0 2 X肝癌细胞中无明显的细胞凋亡发生,研究发现p2 7的表达水平发生了明显下调,而细胞周期蛋白D和细胞周期蛋白E的表达水平发生了明显上调;当pcDNA3 hbxip质粒与pCMV X质粒进行共瞬时转染时,细胞凋亡发生率由pcDNA3质粒与pCMV X质粒共转染时的2 9 2 %下降为13 3% ,p2 7的表达水平发生了下调,但细胞周期蛋白D和细胞周期蛋白E的表达水平无明显变化.研究结果表明,瞬时转染一定剂量的x基因可导致肝癌细胞发生凋亡,细胞周期相关蛋白p2 7、细胞周期蛋白D和     

增加bax基因表达促进紫杉醇诱导的食管癌细胞凋亡

为促进紫杉醇诱导的食管癌细胞凋亡,探索克服耐药、提高紫杉醇疗效的新途径 ,构建了ｂａｘ基因可诱导的真核表达载体,并用荧光素酶基因系统测定也金属硫蛋白启动子在食管癌细胞中的诱导表达及控制能力。将ｂａｘ基因转入食管癌细胞Ｅｃａ１０９中,用免疫细胞化学方法测定了Ｂａｘ蛋白表达,并以ＴＵＮＥＬ、ＤＮＡ梯带、流式细胞术等方法分析了转染ｂａｘ对紫杉醇的诱导细胞凋亡的促进作用。结果表明,１４０μｍｏｌ／ＬＺｎｓ     

CDK1 siRNA干扰在Taxol诱导细胞凋亡中的作用

目的研究转染细胞周期依赖性蛋白激酶1（cyclin．dependent kinase1,CDK1）siRNA、以及转染后进行凋亡刺激对细胞周期和凋亡的影响,探讨CDK1在细胞凋亡中的确切作用,揭示细胞周期与细胞凋亡协调的分子机制。方法以人宫颈癌细胞株HeLa细胞为研究对象,脂质体转染CDK1siRNA,转染后48h加紫杉醇（Tax01）（20μg／m1）刺激凋亡,Western印迹检测CDK1和抗凋亡蛋白BCL2表达,AnnexinV／PI法检测细胞的凋亡,流式细胞仪分析DNA含量检测细胞周期。结果转染CDK1 siRNA后,CDK1蛋白的表达下降,细胞周期G2／M期比例增加,细胞凋亡率与对照相比没有明显升高。只加Taxol刺激12h后细胞凋亡率增加并伴有S期和G2／M期比例增加。转染CDKlsiRNA后再用Taxol刺激,其细胞凋亡率没有明显改变,G2／M期阻滞效应也没有叠加。BCL2蛋白只在加Taxol刺激组表达下降,与CDK1表达减少没有相关性。结论siRNA沉默导致的CDK1表达降低只导致细胞周期G2／M期阻滞,没有引起细胞凋亡;CDK1的表达降低对紫杉醇所诱导的细胞周期阻滞和细胞凋亡效应没有明显影响。     

p53调控骨关节炎软骨细胞凋亡

肿瘤抑制蛋白p53是一种可以有效调节哺乳动物细胞生长的核磷酸化蛋白质。p53表达增加能够激活一系列细胞基因,通过抑制多个细胞周期蛋白依赖性激酶导致细胞周期停滞并凋亡。有研究表明,骨关节炎(osteoarthritis,OA)软骨细胞中,p53的表达高于正常软骨细胞,通过下调p53表达能够减少软骨细胞凋亡,进而预防和缓解骨关节炎病变,这可能与线粒体凋亡途径密切相关,但是具体机制尚不明确。本文通过综述近年来p53调控骨关节炎软骨细胞凋亡的文献资料,为骨关节炎机制和治疗有关研究提供理论基础。     

人乳头瘤病毒E6蛋白在细胞凋亡中的作用

细胞凋亡是细胞体在内、外特定的生理或病理因素诱导下发生的程序性死亡.目前认为,细胞内的基因直接调控细胞凋亡的发生与发展,细胞外部因素通过信号转导而影响这些基因的表达或其表达产物的活化,间接控制细胞凋亡.病毒也可以通过影响凋亡信号转导通路中相关蛋白的活性及相关基因的表达而干扰正常的细胞周期和细胞凋亡.     

紫杉醇对NK-92MI细胞杀伤功能及凋亡的影响

探讨紫杉醇对人自然杀伤细胞系NK-92MI细胞株杀伤活性及凋亡的影响。用不同浓度的紫杉醇处理NK.92MI细胞后,测定NK-92MI细胞的增殖率和对靶细胞的杀伤作用;同时检测NK·92MI细胞凋亡率及凋亡相关基因Bcl-2、Ba】【的表达。结果表明,紫杉醇可以抑制NK-92MI细胞增殖并且降低其杀伤活性,机制可能是通过诱导NK.92MI细胞的凋亡,而后者与Bcll2/Ba】【基因表达增高有关。     

端粒酶与细胞周期、细胞凋亡及癌基因的关系

端粒酶是一种核糖核蛋白酶,能通过延长端粒而维持染色体的稳定性,并使得细胞永生化,是目前已知的最为广谱的肿瘤分子标记物;端粒酶活性随细胞周期运行而改变,并受细胞周期调节蛋白、癌基因和抑癌基因的调控,且与细胞凋亡的发生有着一定的相关性。     

卵泡颗粒细胞凋亡相关蛋白的研究进展

哺乳动物的卵巢中存在大量卵泡。大多数卵泡在发育过程中发生闭锁而消失,只有少数可以发育到成熟而排卵。卵泡是由卵母细胞与其周围的颗粒细胞构成的。卵泡颗粒细胞的凋亡是卵泡闭锁的主要原因。颗粒细胞凋亡相关蛋白通过参与凋亡通路及凋亡信号转导调节凋亡。本文就哺乳动物卵泡颗粒细胞凋亡相关蛋白的研究进展进行综述。     

Apoptosis in the Nervous System

Apoptosis (from the Greek apoptosis, i.e., falling of leaves) is the phenomenon of programmed cell death, which plays an important role in the normal embryonic development and maintenance of the homeostasis of the differentiated tissues of adult organisms. Completion of the apoptosis process is accompanied by specific morphological and biochemical changes in the involved cells. Various disturbances in the control of apoptosis underlie various neurodegenerative diseases, the formation of malignant tumors, autoimmune disturbances, and developmental abnormalities. A deficit of neurotrophic factors leads to apoptosis of neurons. The survival of specific cell populations of neurons is controlled by neurotrophic factors and their combinations. Oncogene bcl-2, a repressor of cell death, belongs to the better-studied factors controlling apoptosis. The terminal stages of cell death, including the death of neurons, depend on the activation of caspases, specifically caspase-1 (interleukin-1-converting enzyme). Ca²⁺and reactive forms of oxygen play an important role in the initiation of apoptosis by changing the mitochondrial permeability. Neuregulin, a factor of neuronal origin, is the main controlling factor in apoptosis of Schwann cells, and this process determines the size of their definitive population. Fibroblast growth factor b diminishes the apoptosis of Schwann cells in regenerating nerve fibers.     

Antiresorptive agents and osteoclast apoptosis

Antiresorptive agents have proven to be effective therapies for the treatment of bone diseases associated with excessive osteoclast activity. Decreased osteoclast formation, inhibition of osteoclast actions, and reduced osteoclast survival represent mechanisms by which antiresorptive agents could act. The goals of this article are to present the evidence that antiresorptive agents can decrease osteoclast survival through apoptosis, to review the mechanisms by which they are thought to activate the apoptotic process, and to consider whether the actions on apoptosis fully account for the antiresorptive effects. As background, the apoptotic process will be briefly summarized together with the evidence that factors that promote osteoclast survival affect steps in the process. Following this, therapeutic agents that are both antiresorptive and can stimulate osteoclast apoptosis will be discussed. Other bone therapeutic agents that are either antiresorptive or apoptotic, but not both, will be described. Finally, newer antiresorptive compounds that elicit apoptosis and could represent potential therapeutic agents will be noted.     

Apoptosis: why and how does it occur in biology?

The literature on apoptosis has grown tremendously in recent years, and the mechanisms that are involved in this programmed cell death pathway have been enlightened. It is now known that apoptosis takes place starting from early development to adult stage for the homeostasis of multicellular organisms, during disease development and in response to different stimuli in many different systems. In this review, we attempted to summarize the current knowledge on the circumstances and the mechanisms that lead to induction of apoptosis, while going over the molecular details of the modulator and mediators of apoptosis as well as drawing the lines between programmed and non-programmed cell death pathways. The review will particularly focus on Bcl-2 family proteins, the role of different caspases in the process of apoptosis, and their inhibitors as well as the importance of apoptosis during different disease states. Understanding the molecular mechanisms involved in apoptosis better will make a big impact on human diseases, particularly cancer, and its management in the clinics.     

凋亡抑制蛋白IAP及其调控

调亡过程中关键参与者是caspase家族的多种成员,它们在凋亡过程中要受到严格调控。凋亡抑制蛋白IAP通过抑制caspase的活性从而参与对凋亡的调控,所以IAP的结构特征及其调控机制具有重要意义。     

天然药物活性成分诱导白血病细胞凋亡研究进展

细胞凋亡是由基因控制的细胞主动死亡过程。现代研究表明,白血病与细胞凋亡密切相关。本文综述了天然药物活性成分对白血病细胞凋亡的影响。     

Enhanced expression of adipocyte-type fatty acid binding protein in murine lymphocytes in response to dexamethasone treatment

Fatty acids have a great influence on the process of lymphocyte apoptosis which is considered as a modulating factor of immune response in both humans and animals. However the mechanism underlying the function of fatty acids in the process of lymphocyte apoptosis is not fully understood. In this study we show that the appearance of adipocyte-type fatty acid binding protein (A-FABP) is induced upon administration of dexamethasone (DEX) in both in vivo and cultured lymphocytes, and its distinct nuclear localization occurs in close relation to the DEX-induced apoptosis process. In immuunohistochemistry of mouse spleen, A-FABP-immunoreactivity starts to occur 3 h after DEX stimulation, and it massively localizes in the nucleus 8 h after the treatment, while no A-FABP-immunoreactivity is discerned in the lymphocytes of normal as well as 24 h post-injection spleen. In the murine T-cell leukemia CTLL-2 cells, A-FABP-immunoreactivity is also induced in both of the cytoplasm and nucleus when the apoptosis is induced by IL-2 retrieval together with DEX treatment, while in the presence of IL-2 A-FABP-immunoreactivity is confined to the cytoplasm with DEX trreatment. On the other hand, A-FABP-immunoreactivity is not detected by IL-2 retrieval alone. The present findings altogether suggest that A-FABP and its ligands, fatty acids, play an important role in the process of apoptosis and the immune modulation induced by DEX.     

Modulation of death receptor-mediated apoptosis by CK2

Protein kinase CK2 has long been known to be involved in cell growth and proliferation. Recent work has also implicated its role in the suppression of apoptosis. We originally documented that removal of survival or growth stimuli resulted in rapid loss of CK2 from the nuclear matrix and chromatin which preceded induction of apoptosis. Further, we demonstrated that overexpression of CK2 in cells promotes suppression of drug-mediated apoptosis. In the present work, we have extended these observations to demonstrate that CK2 can influence apoptosis mediated via the death receptors. Overexpression of CK2 resulted in suppression of apoptosis mediated by TNF-α, TRAIL, and Fas-L in cells responsive to these ligands, whereas downregulation of CK2 resulted in augmentation of apoptosis mediated by these ligands. To our knowledge, this is the first report to show that receptor-mediated apoptosis can be modulated by changes in CK2 in prostate cancer cells. Based on our previous observations together with the evidence presented here, we propose that CK2 has an impact on the process of apoptosis mediated by diverse type of mechanisms thus playing a global role in regulation of apoptotic activity in cells.     

果蝇变态过程中的细胞凋亡和细胞自噬

程序化细胞死亡(programmed cell death,PCD)分为I型PCD细胞凋亡(apoptosis)和II型PCD细胞自噬(autophagy)。果蝇等完全变态昆虫有2种类型的器官:即细胞内分裂器官(如脂肪体、表皮、唾液腺、中肠、马氏管等)和有丝分裂器官(复眼、翅膀、足、神经系统等)。在昆虫变态过程中,细胞内分裂器官进行器官重建,幼虫器官大量发生细胞凋亡和细胞自噬到最后完全消亡,同时成虫器官由干细胞从新生成;而有丝分裂器官则由幼虫器官直接发育为成虫器官。在果蝇等昆虫的变态过程中,细胞凋亡和细胞自噬在幼虫器官的死亡和成虫器官的生成中发挥了非常重要的作用。文章简要介绍细胞凋亡和细胞自噬在果蝇变态过程中的生理功能和分子调控机制。     

昆虫卵子发生过程中细胞凋亡的研究进展

细胞凋亡是动物发育过程中的基本生命现象,是多细胞生物体一种重要的自我稳定机制。除体细胞发生凋亡外,生殖细胞在其发生过程中也有细胞凋亡。对近10年来昆虫卵子发生过程中细胞凋亡的研究作了综述。重点关注昆虫卵子发生过程中细胞凋亡发生的阶段、凋亡的形态特征、凋亡的调控及意义等,以期为相关研究提供基础资料。